Skip to main content

Table 1 Schedule of data collection

From: Three-day regimen of oseltamivir for post-exposure prophylaxis of influenza in hospital wards: a study protocol for a prospective, multi-center, single-arm trial

 

Before PEPa

Observation period

Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

Informed consent

X

       

Clinical assessmentb

X

       

Laboratory testc

X

       

PEPa

 

X

X

X

    

Fever

 

X

X

X

X

X

X

X

Respiratory symptomsd

 

X

X

X

X

X

X

X

Immunochromatographic testinge

 

X

X

X

X

X

X

X

Adverse events

 

X

X

X

X

X

X

X

  1. aPost-exposure prophylaxis
  2. bClinical assessment: history including age, sex, body weight, influenza vaccination, past infection with influenza, underlying disease and medical history
  3. cLaboratory test: hemoglobin, white blood count, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatinine
  4. dRespiratory symptoms: cough or sneezing
  5. eIf the close contacts with index patients with influenza have fever or respiratory symptoms within 7 days after PEP, immunochromatographic testing of influenza will be carried out